HomeStock ScreenerParnax LabFinancial Statements

Parnax Lab Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Parnax Lab (PARNAXLAB) reported revenue ₹72 Cr, net profit ₹2 Cr and EPS ₹1.90, with a net profit margin of 2.8% and ROE of 2.1%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Examine PARNAXLAB quarterly performance for recent quarterly revenue, profit and EPS trends.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 2.78% 2026 data
EBITDA Margin 9.72% 2026 data
Operating Margin 7.00% 2026 data
Return on Assets 0.88% 2026 data
Return on Equity 2.11% 2026 data

Balance Sheet Ratios

Current Ratio 2.46 2026 data
Equity Ratio 41.67% 2026 data
Asset Turnover 0.32 2026 data

PARNAXLAB Revenue, Net Profit & EBITDA — Year-on-Year Growth

PARNAXLAB YoY (Mar 2025 vs Mar 2026) — revenue +44.0%, net profit -33.3%, expenses +54.8%. For live price, earnings ratios and company overview, see PARNAXLAB screener.

Revenue Growth
+44.0%
Year-over-Year
Net Profit Growth
-33.3%
Year-over-Year
Expense Growth
+54.8%
Year-over-Year
Assets Growth
+20.0%
Year-over-Year
Equity Growth
+14.5%
Year-over-Year
Operating Cash Flow Growth
+100.0%
Year-over-Year
Investing Cash Flow Growth
+50.0%
Year-over-Year
Financing Cash Flow Growth
-206.7%
Year-over-Year

PARNAXLAB Income Statement — Revenue, EBITDA & Net Profit

Parnax Lab revenue ₹72 Cr, EBITDA ₹7 Cr, net profit ₹2 Cr, EPS ₹1.90 (2026) — net profit margin 2.8%. Analyse PARNAXLAB promoter holding to track promoter, FII and institutional holdings.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021 Sept 2020 Mar 2020 Jun 2020 Dec 2020 Sept 2019 Mar 2019 Jun 2019 Dec 2019 Sept 2018 Mar 2018 Jun 2018 Dec 2018 Sept 2017 Mar 2017 Jun 2017 Dec 2017 Sept 2016 Mar 2016 Jun 2016 Dec 2016 Sept 2015 Mar 2015 Jun 2015 Dec 2015
Revenue 72 63 50 54 64 49 47 50 40 43 41 49 51 43 48 37 47 36 21 29 51 27 24 18 25 26 21 21 26 43 23 23 24 36 22 23 25 25 19 22 27 19 26 16 17
Expenses 65 55 42 46 57 41 41 42 36 37 36 42 45 38 41 31 40 30 21 25 44 22 23 15 22 23 19 19 24 37 21 21 21 31 19 21 22 22 17 18 23 16 23 14 15
EBITDA 7 9 7 8 7 8 6 9 5 6 5 7 6 6 7 5 7 6 0 3 7 5 1 3 3 3 1 2 1 6 1 3 2 5 2 2 3 3 2 3 4 3 3 3 3
Operating Profit Margin % 7.00% 13.00% 14.00% 14.00% 9.00% 15.00% 13.00% 17.00% 11.00% 12.00% 12.00% 13.00% 12.00% 13.00% 15.00% 14.00% 16.00% 16.00% -2.00% 12.00% 14.00% 18.00% 2.00% 15.00% 11.00% 11.00% 4.00% 10.00% 5.00% 12.00% 2.00% 11.00% 8.00% 13.00% 10.00% 9.00% 11.00% 13.00% 8.00% 15.00% 14.00% 17.00% 10.00% 17.00% 14.00%
Depreciation 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Interest 2 1 1 1 2 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Profit Before Tax 3 5 4 5 3 5 3 5 2 2 2 4 3 3 4 3 4 3 -3 1 5 2 -2 0 0 0 -1 0 -1 4 -1 1 0 3 0 0 1 1 0 2 2 2 1 1 1
Tax 1 2 1 1 1 2 1 1 0 1 1 1 1 1 4 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 2 4 3 3 3 3 2 4 1 2 1 3 2 2 0 2 3 3 -3 1 5 2 -3 0 0 0 -1 0 -1 4 -1 1 0 3 0 0 1 1 0 2 2 1 1 1 1
Earnings Per Share (₹) 1.90 3.15 2.55 2.85 2.37 2.97 1.95 3.47 1.06 1.63 1.30 2.90 1.90 1.83 -0.18 1.97 2.96 3.38 -3.65 1.15 5.37 2.82 -3.02 0.27 0.14 0.42 -0.82 0.09 -0.97 4.89 -0.82 0.85 0.46 3.43 0.35 0.18 0.75 1.27 0.31 1.88 1.91 1.65 1.29 1.00 0.99

PARNAXLAB Balance Sheet — Assets, Liabilities & Shareholders' Equity

PARNAXLAB total assets ₹228 Cr, total equity ₹95 Cr, total liabilities ₹ Cr (2026) — ROE 2.1%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 228 190 190 145 154 106 107 95 87 86 79 83
Current Assets 91 65 73 57 71 39 46 37 37 31 31 38
Fixed Assets 126 88 90 77 72 60 58 51 44 47 38 36
Capital Work in Progress 11 29 21 2 3 5 3 0 0 0 2 1
Investments 36 0 0 0 0 0 0 0 0 0 0 0
Other Assets 2 72 80 66 78 42 46 43 43 38 39 46
LIABILITIES
Total Liabilities
Current Liabilities 37 32 35 20 24 19 22 23 18 18 23 27
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 95 83 72 62 48 33 33 36 33 31 28 25
Share Capital 12 12 12 12 10 9 9 9 9 9 9 9
Reserves & Surplus 84 72 60 51 37 24 24 27 24 23 19 17

PARNAXLAB Cash Flow Statement — Operating, Investing & Financing

Parnax Lab operating cash flow ₹32 Cr, investing ₹-16 Cr, financing ₹-16 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 32 16 21 9 6 9 9 13 16 4 0
Investing Activities -16 -32 -10 -17 -7 -13 -11 -5 -10 -6 -4
Financing Activities -16 15 -14 12 0 5 1 -7 -5 1 6
Net Cash Flow 0 -1 -3 4 0 0 -1 1 0 -2 2